Australia's largest stock trading and investment forum Australia's #1 stock forum

CMY

Click for more information

0.00%

0.5¢ capital mining limited

explination, page-7

First 7 Last

Share
Profile

Follow
patto66

2,060 Posts.

384

27/04/17

23:47

Post #: 24314403
Share

Originally posted by patto66 ↑

If you notice the timing of the announcements made, then look at what the flavour of the month was at that time it will give you a good indication. Not sure what will come of the BCC deal. Can't see them getting much more then 5-10% or perhaps the rights to sell for BCC in Australia or something. Or perhaps it all falls over again. The directors get paid huge salaries for a company with no revenue and last time I checked they also pay consulting fees to chapmans, which by pure coincidence, two of cmy directors are also directors there. Not sure if this is still the case or not. Will show in the financials. Every dog has their day and I'm not saying nothing will come of any of the potential deals they have on the table, but if you buy, tred with caution and take profit where possible. All imo of course.

Expand

Just had a quick look, page 21/22 of the half yearly will give you all the info you need regarding consulting fees. Good luck with your research and investment.

CMY Price at posting: 1.6¢ Sentiment: Hold Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

Emerald & Azure score Digger & Dealer awards

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

Bitcoin: Current State of Play & Where to Next | Swyftx

TNC

True North increases silver metal at QLD's Vero deposit by 20%

Revolutionary inverter technology leads the clean energy charge

TKM

Trek Metals jumps 5% as gold & REE drill run kicks off at Christmas Creek in the Kimberley

Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling

HZR

Hazer Group reports ten days of continuous operation at graphite-manufacturing test facility

Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market

NEU

Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress

There are more pages in this discussion • 12 more messages in this thread...

First 7 Last

Add CMY (ASX) to my watchlist